Clinical Trial
Study Details
Enrollment
100
Interventions
Description
Dispersible (20 mg) tablet
Name
zinc sulfate
Type
Drug
Description
Dispersible tablet
Name
Placebo
Type
Drug
Phase
Phase 2
Phase 3
Status
COMPLETED
Study ID #
NCT06561061
Study Type
Interventional
Summary
A randomized double-blinded placebo-controlled trial of zinc to reduce the incidence of severe or invasive infections in Ugandan children with sickle cell anemia (SCA)
Study Overview
Conditions
Description
The study will be a randomized, placebo-controlled, double blind clinical trial in which 100 Ugandan children 1.00-4.99 years of age with SCA will receive zinc (20 mg oral dispersible tablet daily) or placebo (identical to zinc in appearance) for 6 months. The primary study outcome will be incidence of infection (all causes).
Contacts and Locations
Locations
Facility
Jinja Hospital
Jinja
Uganda
GeoPoint
0.43902, 33.20317